Compare immunogenicity % reactogenicity of 2 formulations of GSK Biologicals’ DTPa-HBV-IPV/Hib vaccine (new vs current) given in healthy infants. The DTPa-HBV-IPV vaccine (new formulation) will also be assessed in a 3rd group of subjects
Combined Diphtheria, Tetanus, Acellular Pertussis Adsorbed, Hepatitis B (Recombinant), Inactivated Polio Vaccine
Acellular pertussis; Diphtheria; Hepatitis B; Poliomyelitis; Tetanus
Phase 3
An annotated case report form is not available for this study. A blank case report form will be provided.
September 2013